Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial

Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial

Abstract Background The FOCUS study evaluated the efficacy of migraine preventive medications across different countries within the same patient population, particularly for patients with difficult-to-treat migraine. These prespecified subgroup analyses evaluated efficacy by country in the FOCUS stu...

Full description

Bibliographic Details
Main Authors: Egilius L. H. Spierings, Mikko Kärppä, Xiaoping Ning, Joshua M. Cohen, Verena Ramirez Campos, Ronghua Yang, Uwe Reuter
Format: Article
Language:English
Published: BMC 2021-04-01
Series:The Journal of Headache and Pain
Subjects:
Migraine
Prevention
Fremanezumab
Anti-CGRP
Efficacy
Country
Online Access:https://doi.org/10.1186/s10194-021-01232-8

Internet

https://doi.org/10.1186/s10194-021-01232-8

Similar Items